A. B. C. A. B. C. D.: Clinical Chemistry II - Prelims (Bandala)
A. B. C. A. B. C. D.: Clinical Chemistry II - Prelims (Bandala)
A. B. C. A. B. C. D.: Clinical Chemistry II - Prelims (Bandala)
Major parts:
Cortex Renal Functions Renal Functions (Strasinger)
Medulla a. Filters blood a. Renal blood flow
Pelvis
b. Excrete wastes and excess b. Glomerular filtration
Nephron functional unit of the kidney
water thru urine c. Tubular reabsorption
Cortical
c. Regulate blood pressure, d. Tubular secretion
- Found in the renal cortex
volume pH and salt
- Peritubular capillary
- Upper glomerulus
Juxtamedullary
- Vasa recta (straight vessels)
- Lower glomerulus
CREATININE
- Synthesized primarily in the liver from
o Arginine
o Glycine
o Methionine
- Transported to tissues and is converted to phosphocreatine
o Serves as a high-energy source
- Endogenous substance
- With a MW of 113 Da
- Waste product of muscle metabolism
o Produced by the muscle from creatine and creatine
phosphate thru non-enzymatic dehydration process
4 Clinical Chemistry II Prelims (Bandala)
- Released into the circulation at a relative constant rate in
proportional to an individuals muscle mass
Creatine Creatinine
Muscle diseases Associated with abnormal
- Muscular dystrophy renal function
-
-
-
Poliomyelitis
Hyperthyroidism
Trauma
( mgdL ) U ( 24mL
U Cr Cr
hours
)
1.73
mg 1440 minutes A
P (
dL )
- Most widely used marker for GFR
Cr
o Advantages 24 hours
Endogenous substance with constant rate of production
Not bound to plasma proteins Cockroft-Gault formula (mL/minute) (Cockroft, 1976)
Not reabsorbed by the tubules ( [ 140 Age ] [ IBW ] )
Only a small amount is secreted by the tubules ; multiply by 0.85 if female
- Why measure creatinine? (72 SCr)
o To determine sufficiency of kidney function and the severity of IBW = ideal body weight
kidney damage SCr = serum creatinine concentration
IBW is calculated by the ff. formula:
o To monitor progression of kidney disease Males: IBW = 50kg + 2.3 kg for each inch over 5
ft
Creatininase-CK
Phosphoenolpyruvate+ ADP PK pyruvate+ ATPavoided
+
+ LD Lactate+ NAD
Pyruvate+ NADH + H
Creatinine+ H 2 O Creatininase Creatine
Creatine H 2 O Creatininase Sarcosine+Urea
Creatininase-H2O2
Sarcosine +O 2 + H 2 O Sarcosine oxidase Glycine+CH 2 O+ H 2 O 2
H 2 O2 +colorless substrate Peroxidase Colored product + H 2 O
Lipemic samples produce erroneous results
o Fasting is NOT required
Urine
o Urine specimen should be refrigerated or frozen if longer than 4 days.
GLOMERULAR FILTRATION TESTS: CREATININE (CONT.)
Interfering substances in urine
Ascorbic acid interfere peroxidase Secretion of hydrogen
Glucose ions & production and
Protein, urea secretion of NH4+ by
Alpha-ketoacids/ketones cells in DCT
Cephalosporins, Dopamine, Lidocaine
o False increase
Hemoglobin and bilirubin
o false decrease
Uric acid
o Decreased in kinetic methods
INULIN
- Polymer of fructose
- Extremely stable substance that is not reabsorbed or secreted by the tubules
- Not a normal body constituent
- Exogenous procedure
BETA2-MICROGLOBULIN
- Has MW of approximately 11,800 Da
- Dissociates from human leukocytes antigens at a constant rate
- Rapidly removed from the plasma by glomerular filtration then reabsorbed completely by the PCT
- Not reliable in patients with immunologic conditions ( production)
Multiple myeloma
Lymphoma
CYSTATIN C
- Has MW of app 13,000 Da
- Inhibitor of cysteine proteinase
- Produced by all nucleated cells at a constant rate
- Freely filtered and completely reabsorbed in the PCT (normally not seen in urine)
- Plasma concentrations appear to be unaffected by gender, race, age and muscle mass
- Measurements are difficult and expensive NOT routinely used
Other GF tests
Beta trace protein
Tryptophan glycoconjugate
Use of Radioisotopes
6 Clinical Chemistry II Prelims (Bandala)
7 Clinical Chemistry II Prelims (Bandala)
b. URICASE METHOD
Uricase catalyzed the oxidation of UA to allantoin
Measures the differential absorption of uric acid Uric acid+2 H 2 O+O2 Uricase allantoin+CO 2+ H 2 O2
and allantoin at 293 nm
More specific
Interfering substances (negative)
Hemoglobin
Xanthine
AMMONIA
- Analytical/Lab Methods
Complicated by its
Low concentration
Instability
Increased Decreased
10 Clinical Chemistry II Prelims
(Bandala)
Ammonium salts Diphenhydramine
Pervasive contamination
Two approaches
Asparginase Lactobacillus
a. Two-step approach in Barbituates acidophilus which ammonia is isolated from the
sample and then Diuretics Lactulose assayed
b. Involves direct measurement of ammonia by an
Ethanol Ledovia
enzymatic method or ion selective electrode
GLUTAMATE Hyperalimentation Several antibiotics
DEHYDROGENASE ASSAY
- Specimen requirement Narcotic analgesics
Whole blood ammonia
concentration increases rapidly following specimen collection because of in vitro amino
acid deamination
Venous blood should be obtained without trauma and placed on ice immediately
Heparin and EDTA
Samples should be centrifuged at 0C to 4C within 20 minutes of
collection and plasma or serum is removed
Hemolysis should be avoided
TOPIC 3 Falciform
LIVER FUNCTION ligament
Liver - separates
Anatomy: right and
Anterior to the gallbladder left lobes
storage of bile
of the liver
o emulsifies fats
o purely for excretion of waste
products
where the excretory waste products
of liver are passed out
Blood supplies:
o Hepatic artery
- contains oxygenated blood
o Portal vein
- Contains nutrient rich blood from
Intestines
Stomach
Spleen
- Unoxygenated blood
Hepatic vein to
circulation
- Waste Common bile duct
Hepatic lobules
o Functional unit
o 6 sided
o Portal triad
Bile duct
Hepatic artery
Portal vein sinusoids
Hepatocyte
o 80-90%
o Aids in regeneration
Increase proliferation and cell growth
Kupffer cell
responsible for phagocytosis of unwanted
substances
found alongside of hepatocyte
Physiology:
4 general functions
o Excretion and secretion
o Synthesis
o Detoxification
o Storage
11 Clinical Chemistry II Prelims (Bandala)
a. Synthesis
One of the most important function:
Metabolism of carbohydrates
o Use the glucose for its own cellular energy requirements
o Circulate the glucose for use at the peripheral tissues
o Store glucose as glycogen
o Responsible for gathering free fatty acids and breaking
them down to produce acetyl-CoA
o Acetyl coA helps in synthesis of triglyceride and
o Almost all proteins (albumin) are synthesized by the liver
b. Detoxification and drug metabolism
2 mechanisms:
Bind the material reversibly as to inactivate the compound
Chemically modify the compound so it can be excreted
c. Excretion/Secretion
Secretory Functions
Bile
Emulsifying agent
Facilitate fat digestion
Purely of waste product
Has no enzymes
o Bile acids
Cholesterol
o Cholic acids
o Chenodeoxycholic acid
o Bile salts
o Bile pigments
Bilirubin main waste product
2 UDP-glucoronic 2 UDP
acid
Uridyl Diphosphate Glucuronyl Transferase (UDPGT)
enzyme responsible for the conjugation of
B1, forming B2
B1 B2
Unconjugated bilirubin Conjugated bilirubin
Water insoluble Water Soluble
Non-Polar Bilirubin Polar Bilirubin
Indirect reacting Direct reacting
Hemobilirubin Cholebilirubin
Free bilirubin/Slow One-minute/Prompt bilirubin
Pre hepatic bilirubin Post hepatic bilirubin
Bilirubin monoglucoronide Bilirubin diglucoronide
CLINICAL SIGNIFICANCE
JAUNDICE
Icterus term used for sampes
Characterized by yellow discoloration
o Prehepatic jaundice
o Hepatic jaundice
o Post hepatic jaundice
Prehepatic Jaundice
o Excessive amount of bilirubin is presented go the liver for
metabolism
Hemolysis
Hemolytic anemia
Malaria
Increased B1
o Rarely have bilirubin levels that exceeds 5 mg/dL because the
liver is capable of handling the overload
o Unconjugated hyperbilirubinemia
Hepatic Jaundice
12 Clinical Chemistry II Prelims (Bandala)
o Result from impaired cellular uptake of bilirubin, defective
conjugation, abnormal secretion of bilirubin by the liver cell
Hepatic Jaundice:
B1
o Gilberts Syndrome elevated B1
Bilirubin transport deficit Gilberts Syndrome
Characterized by impaired cellular uptake of bilirubin Crigler-Najjar Syndrome
Characterized by a 70-80% reduction in the Lucey-Driscoll Syndrome
glucuronidation activity of the enzyme, UGT1A1
Characterized by intermittent unconjugated B2
hyperbilirubinemia in the absence of hemolysis and Dubin-Johnson Syndrome
underlying liver disease due to a defective Rotors Syndrome
conjugation system
No symptoms but may have mild icterus
o CriglerNajjar Syndrome
Conjugation deficit
Characterized by deficiency of the enzyme UDPGT
Type 1
o Complete absence of UDPGT
o Total absence of B2 Production
Type 2
o Less severe deficience of UDPGT
o Dubin-Johnson syndrome
Bilirubin Excretion Deficit
Transporters:
An autosomalorecessive
MRP2disease which Resistance
Multi-Drug presents shortly
Associated
after birth with an increase of conjugated bilirubin
Protein 2
without elevation of liver enzymes (ALT, AST)
o cMOAT2 - Canalicular Multispecific Organic
Defects in the adenosine triphosphate (ATP)-binding
Anion Transporter 2
cassette (ABC) canalicular multispecific organic anion
o ABCC2 gene that encodes MRP2
transporter, M2/cMOAT/ABCC2
Elevated total bilirubin and B2
o Rotors syndrome
Liver cells are not pigmented
Hypothesized to be due to a reduction in the concentration
or activity of intracellular binding proteins such as
ligandin
o Same symptoms with Dubin-Johnson Syndrome
o Increased B2
o Lucey-Driscoll Syndrome
Familial form of unconjugated hyperbilirubinemia caused
by a circulating inhibitor of bilirubin conjugated
Circulating enzyme inhibitors
Posthepatic Jaundice
Biliary obstructive jaundice
o Tumor
o Gallstones
*Cirrhosis
Scar tissue replaces normal, healthy liver tissue
Blocks the flow of blood through the organ and prevents the liver from
functioning properly
Secondary to chronic alcoholism and chronic hepatitis C virus infection
ANALYSIS OF BILIRUBIN
Ehrlichs reaction (1883)
o Urine bilirubin reacted to diazotized sulfanilic acid
Hydrochloric acid
Sulfanilic acid
o Classic diazo reaction
Van den Bergh (1913)
o Using serum
o Used alcohol accelerator for the coupling of bilirubin to
diazotized sulfanilic acid, solubilizing unconjugated bilirubin
Malloy-Evelyn method (1937)
o Serum bilirubin
o Classic diazo reaction with a 50% methanol solution as an
accelerator
o Final reaction: Pink to purple azobilirubin
SPECIMEN REQUIREMENTS
Serum
o Free from hemolysis and lipemia
o Should be stored in the dark
If left unprotected from light, bilirubin values may
reduce by 30%-50% per hour
o Measure ASAP or within 2-3 hours after collection
Clinical Chemistry II Prelims (Bandala)
ENZYMES
Enzymes Enzymology
- Biologic catalysts - Study of enzymes
- Hasten chemical reactions o Ac
o Not consumed during the reactions tivi
o Not
ty
undergoi
ng a
chemical
change
after the
reactions
Nomenclature of Enzymes
1. Substrate + -ase 3. Enzyme Commission Nomenclature (E.C.)
Lipid = lipase E.C. 1.1.1.21
Ester = esterase 1st digit = class
Protein = protease 2nd digit = subclass
Lactose = lactase 3rd and 4th = serial number
Starch = amylase
2. Reaction it catalyzes
Oxidase = oxidation
Reductase = reduction
Hydrolase = hydrolysis
Dehydrogenase = remove hydrogen atoms, transferring them to a coenzyme
Decarboxylase = remove carboxyl groups
CLASSIFICATIONS OF ENYZYMES
1. OXIDOREDUCTASES
Oxidation and reduction Classifations of Enzymes
o Oxidation removal of H ion 1. Oxidoreductases
o Reduction accept H ion 2. Transferases
o E.C. 1.1.1.27 : L-lactate
3. Hydrolases
NAD + Oxidoreductase
4. Lyases
Lactate Dehydrogenase
5. Isomerases
6. Ligases
2. TRANSFERASES
Transfer of functional groups other than hydrogen from one substrate to another
o E.C. 2.6.1.1 :
L-Aspartate: 2-Oxaloglutarate Aminotransferase
Aspartate Aminotransferase
3. HYDROLASES
Hydrolysis of various bonds
Addition of water to a bond resulting in bond breakage
Clinical Chemistry II Prelims (Bandala)
o E.C. 3.2.1.1 : 1,4-D-GlucanGlucanohydrolase
Alpha-Amylase
4. LYASES
Addition of a group to a double bond or the removal of a group to form a double
bond
o Carbonic Anhydrase
o Citrate Lyase
5. ISOMERASES
Rearrange the functional groups within a molecule and catalyze the
conversion of one isomer into another
o Phosphoglycerate mutase
6. LIGASES
Catalyze a reaction in which C-C, C-S, C-O, or C-N bond is made or broken
Accompanied by an ATP-ADP interconversion
TERMS
Substrate Acted upon by the enzyme; Specific
Isoenzyme Different form but with the same action
Cofactor Non-protein molecule
Clinical Chemistry II Prelims (Bandala)
6. Inhibitors
Interfere with enzyme reactions
o Competitive
o Noncompetitive
o Uncompetitive
Clinical Chemistry II Prelims (Bandala)
Phosphatases
Alkaline Phosphatase (ALP)
o Bone
o Liver
Acid Phosphatase (ACP)
o Prostate Gland
o Red Blood Cells
Clinical Chemistry II Prelims (Bandala)